(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÕES FARMACÊUTICAS SÓLIDAS DE ADAGRASIBE

Em AnáliseInvention PatentPCT · US2023030689

Application data

Number

112025002791

Type

Invention Patent

Filing

08/21/2023

Publication

07/22/2025

PCT

US2023030689

Progress at the INPI

  1. Filing08/21/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 08/21/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/22/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MIRATI THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

C. N. (pessoa física)

US

M. K. (pessoa física)

US

M. G. (pessoa física)

US

Technical data

Priority claims

US

63/399,619 · 08/19/2022

US

63/400,640 · 08/24/2022

Abstract

COMPOSIÇÕES FARMACÊUTICAS SÓLIDAS DE ADAGRASIBE. A presente invenção refere-se a composições farmacêuticas na forma sólida que compreendem adagrasibe, adequadas para dosagem oral para tratar indivíduos com câncer; bem como métodos de fabricação das composições e métodos de tratamento de câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

07/22/2025

RPI 2846

Alteração de dados cadastrais

#1.1

02/25/2025

RPI 2825

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.